Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway

被引:344
作者
Elias, Kevin M. [1 ,2 ]
Laurence, Arian [2 ]
Davidson, Todd S. [3 ]
Stephens, Geoffrey [3 ]
Kanno, Yuka [2 ]
Shevach, Ethan M. [3 ]
O'Shea, John J. [2 ]
机构
[1] Howard Hughes Med Inst, NIH, Res Scholars Program, Bethesda, MD 20817 USA
[2] NIAMSD, Mol Immunol & Inflammat Branch, Lymphocyte Cell Biol Sect, Bethesda, MD 20892 USA
[3] NIAID, Cellular Immunol Sect, Immunol Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2007-06-096438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD4(+) helper T (Th) cells play a crucial role in the delicate balance between host defense and autoimmune disease. Two important populations of helper T cells are the proinflammatory, interleukin-17 (IL-17)-producing (Th17) cells and the anti-inflammatory forkhead box P3-positive (FoxP3(+)) T regulatory (Treg) cells. Here we show that all-trans retinoic acid (ATRA) and other agonists of the retinoic acid receptor alpha (RAR alpha) inhibit the formation of Th17 cells and promote FoxP3 expression. Conversely, inhibition of retinoic acid signaling constrains transforming growth factor beta (TGF-beta 1) induction of FoxP3. The effect of ATRA is mediated independently of IL-2, signal transducer and activator of transcription 5 (Stat5) and Stat3, representing a novel mechanism for the induction of FoxP3 in CD4 T cells. As previous studies have shown that vitamin A derivatives are protective in animal models of autoimmune disease, the current data suggest a previously unrecognized role for RAR alpha in the regulation of CD4(+) T-cell differentiation and provide a mechanism for the anti-inflammatory effects of retinoic acid.
引用
收藏
页码:1013 / 1020
页数:8
相关论文
共 45 条
  • [1] RETINOIC ACID SUPPRESSION OF HUMAN-LEUKOCYTE INTERFERON-PRODUCTION
    ABB, J
    ABB, H
    DEINHARDT, F
    [J]. IMMUNOPHARMACOLOGY, 1982, 4 (04): : 303 - 310
  • [2] Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
    Batten, Marcel
    Li, Ji
    Yi, Sothy
    Kljavin, Noelyn M.
    Danilenko, Dimitry M.
    Lucas, Sophie
    Lee, James
    de Sauvage, Frederic J.
    Ghilardi, Nico
    [J]. NATURE IMMUNOLOGY, 2006, 7 (09) : 929 - 936
  • [3] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    Bettelli, E
    Carrier, YJ
    Gao, WD
    Korn, T
    Strom, TB
    Oukka, M
    Weiner, HL
    Kuchroo, VK
    [J]. NATURE, 2006, 441 (7090) : 235 - 238
  • [4] TH-17 cells in the circle of immunity and autoimmunity
    Bettelli, Estelle
    Oukka, Mohamed
    Kuchroo, Vijay K.
    [J]. NATURE IMMUNOLOGY, 2007, 8 (04) : 345 - 350
  • [5] BLALOCK JE, 1977, P NATL ACAD SCI USA, V74, P5382, DOI 10.1073/pnas.74.12.5382
  • [6] Regulatory T-cell therapy: is it ready for the clinic?
    Bluestone, JA
    [J]. NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) : 343 - 349
  • [7] INFLAMMATION AND COLLAGENASE PRODUCTION IN RATS WITH ADJUVANT ARTHRITIS REDUCED WITH 13-CIS-RETINOIC ACID
    BRINCKERHOFF, CE
    COFFEY, JW
    SULLIVAN, AC
    [J]. SCIENCE, 1983, 221 (4612) : 756 - 758
  • [8] IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells
    Burchill, Matthew A.
    Yang, Jianying
    Vogtenhuber, Christine
    Blazar, Bruce R.
    Farrar, Michael A.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (01) : 280 - 290
  • [9] IMMUNITY TO TRICHINELLA-SPIRALIS INFECTION IN VITAMIN-A DEFICIENT MICE
    CARMAN, JA
    POND, L
    NASHOLD, F
    WASSOM, DL
    HAYES, CE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) : 111 - 120
  • [10] Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO